T cell deficiency leads to cognitive dysfunction: Implications for therapeutic vaccination for schizophrenia and other psychiatric conditions

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 21, 2004, Pages 8180-8185

  Kipnis, Jonathan ^a   Cohen, Hagit ^b   Cardon, Michal ^a   Ziv, Yaniv ^a   Schwartz, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DIZOCILPINE; DIZOCILPINE MALEATE; GLATIRAMER; VACCINE;

ADAPTIVE BEHAVIOR; AGE DISTRIBUTION; AIDS RELATED COMPLEX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CELLULAR IMMUNITY; COGNITIVE DEFECT; CONTROLLED STUDY; COPING BEHAVIOR; DEMENTIA; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; MALE; MENTAL DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; T LYMPHOCYTE ACTIVATION; VACCINATION;

AMPHETAMINE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; COGNITION DISORDERS; DIZOCILPINE MALEATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; MAZE LEARNING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PEPTIDES; SCHIZOPHRENIA; STARTLE REACTION; T-LYMPHOCYTES; VACCINATION;

ANIMALIA;

EID: 2542596271     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0402268101     Document Type: Article

References (48)

1. Lieberman, J., Chakos, M., Wu, H., Alvir, J., Hoffman, E., Robinson, D. & Bilder, R. (2001) Biol. Psychiatry 49, 487-499.
2. Velakoulis, D., Pantelis, C., McGorry, P. D., Dudgeon, P., Brewer, W., Cook, M., Desmond, P., Bridle, N., Tierney, P., Murrie, V., et al. (1999) Arch. Gen. Psychiatry 56, 133-141.
3. McCullumsmith, R. E. & Meador-Woodruff, J. H. (2002) Neuropsychopharmacology 26, 368-375.
4. Lewis, D. A., Pierri, J. N., Volk, D. W., Melchitzky, D. S. & Woo, T. U. (1999) Biol. Psychiatry 46, 616-626.
5. Brzustowicz, L. M., Hayter, J. E., Hodgkinson, K. A., Chow, E. W. & Bassett, A. S. (2002) Hum. Hered. 54, 199-209.
6. Falkai, P., Schneider-Axmann, T., Honer, W. G., Vogeley, K., Schonell, H., Pfeiffer, U., Scherk, H., Block, W., Traber, F., Schild, H. H., et al. (2003) Eur. Arch. Psychiatry Clin. Neurosci. 253, 92-99.
7. Javitt, D. C. (1999) Curr. Psychiatry Rep. 1, 25-30.
8. Rummel, C., Hamann, J., Kissling, W. & Leucht, S. (2003) Cochrane Database Syst. Rev., CD004410.
9. de Kloet, R. E. (2003) Endocr. Regul. 37, 51-68.
10. Raison, C. L. & Miller, A. H. (2001) Semin. Clin. Neuropsychiatry 6, 277-294.
11. Amital, H. & Shoenfeld, Y. (1993) Isr. J. Med. Sci. 29, 593-597.
12. Moalem, G., Leibowitz-Amit, R., Yoles, E., Mor, F., Cohen, I. R. & Schwartz, M. (1999) Nat. Med. 5, 49-55.
13. Kipnis, J., Yoles, E., Schori, H., Hauben, E., Shaked, I. & Schwartz, M. (2001) J. Neurosci. 21, 4564-4571.
14. Yoles, E., Hauben, E., Palgi, O., Agranov, E., Gothilf, A., Cohen, A., Kuchroo, V., Cohen, I. R., Weiner, H. & Schwartz, M. (2001) J. Neurosci. 21, 3740-3748.
15. Schwartz, M. & Kipnis, J. (2001) Trends Mol. Med. 7, 252-258.
16. Kipnis, J., Mizrahi, T., Hauben, E., Shaked, I., Shevach, E. & Schwartz, M. (2002) Proc. Natl. Acad. Sci. USA 99, 15620-15625.
17. Kipnis, J., Yoles, E., Porat, Z., Cohen, A., Mor, F., Sela, M., Cohen, I. R. & Schwartz, M. (2000) Proc. Natl. Acad. Sci. USA 97, 7446-7451.
18. Kim, S. K., Wang, K. C., Hong, S. J., Chung, C. K., Lim, S. Y., Kim, Y. Y., Chi, J. G., Kim, C. J., Chung, Y. N., Kim, H. J. & Cho, B. K. (2003) Epilepsy Res. 56, 175-183.
19. Lahti, A. C., Weiler, M. A., Tamara Michaelidis, B. A., Parwani, A. & Tamminga, C. A. (2001) Neuropsychopharmacology 25, 455-467.
20. Tenn, C. C., Fletcher, P. J. & Kapur, S. (2003) Schizophr. Res. 64, 103-114.
21. Whishaw, I. Q. & Auer, R. N. (1989) Psychopharmacology (Berl) 98, 500-507.
22. Ahlander, M., Misane, I., Schott, P. A. & Ogren, S. O. (1999) Neuropsychopharmacology 21, 414-426.
23. Griesbach, G. S., Hu, D. & Amsel, A. (1998) Behav. Brain. Res. 97, 29-38.
24. Moalem, G., Gdalyahu, A., Shani, Y., Otten, U., Lazarovici, P., Cohen, I. R. & Schwartz, M. (2000) J. Autoimmun. 20, 6421-6430.
25. Van den Buuse, M., Garner, B. & Koch, M. (2003) Curr. Mol. Med. 3, 459-471.
26. Aharoni, R., Meshorer, A., Sela, M. & Arnon, R. (2002) J. Neuroimmunol. 126, 58-68.
27. Kerschensteiner, M., Stadelmann, C., Dechant, G., Wekerle, H. & Hohlfeld, R. (2003) Ann. Neurol. 53, 292-304.
28. Weickert, C. S., Hyde, T. M., Lipska, B. K., Herman, M. M., Weinberger, D. R. & Kleinman, J. E. (2003) Mol. Psychiatry 8, 592-610.
29. Egan, M. F., Weinberger, D. R. & Lu, B. (2003) Am. J. Psychiatry 160, 1242.
30. Iida, R., Yamada, K., Mamiya, T., Saito, K., Seishima, M. & Nabeshima, T. (1999) J. Neuroimmunol. 95, 65-72.
31. Schori, H., Yoles, E. & Schwartz, M. (2001) J. Neuroimmunol. 119, 199-204.
32. Wekerle, H. (2002) J. Infect. Dis. 186, Suppl. 2, S140-S144.
33. Fisher, J., Levkovitch-Verbin, H., Schori, H., Yoles, E., Butovsky, O., Kaye, J. F., Ben-Nun, A. & Schwartz, M. (2001) J. Neurosci. 21, 136-142.
34. Schori, H., Kipnis, J., Yoles, E., WoldeMussie, E., Ruiz, G., Wheeler, L. A. & Schwartz, M. (2001) Proc. Natl. Acad. Sci. USA 98, 3398-3403.
35. Bakalash, S., Kessler, A., Mizrahi, T., Nussenblatt, R. & Schwartz, M. (2003) Invest. Ophthalmol. Vis. Sci. 44, 3374-3381.
36. Angelov, D. N., Waibel, S., Guntinas-Lichius, O., Lenzen, M., Neiss, W. F., Tomov, T. L., Yoles, E., Kipnis, J., Schori, H., Reuter, A., et al. (2003) Proc. Natl. Acad. Sci. USA 100, 4790-4795.
37. Aharoni, R., Kayhan, B., Eilam, R., Sela, M. & Arnon, R. (2003) Proc. Natl. Acad. Sci. USA 100, 14157-14162.
38. Kipnis, J. & Schwartz, M. (2002) Trends Mol. Med. 8, 319-323.
39. Linton, P. J. & Dorshkind, K. (2004) Nat. Immunol. 5, 133-139.
40. Wick, G., Berger, P., Jansen-Durr, P. & Grubeck-Loebenstein, B. (2003) Exp. Gerontol. 38, 13-25.
41. Farber, N. B., Jiang, X. P., Heinkel, C. & Nemmers, B. (2002) Mol. Psychiatry 7, 726-733.
42. Schwartz, M., Shaked, I., Fisher, J., Mizrahi, T. & Schori, H. (2003) Trends Neurosci. 26, 297-302.
43. Kipnis, J., Nevo, U., Panikashvili, D., Alexandrovich, A., Yoles, E., Akselrod, S., Shohami, E. & Schwartz, M. (2003) J. Neurotrauma 20, 559-569.
44. Ziemssen, T., Kumpfel, T., Klinkert, W. E., Neuhaus, O. & Hohlfeld, R. (2002) Brain 125, 2381-2391.
45. Iritani, S., Niizato, K., Nawa, H., Ikeda, K. & Emson, P. C. (2003) Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 801-807.
46. Han, B. H. & Holtzman, D. M. (2000) J. Neurosci. 20, 5775-5781.
47. Markowitsch, H. J., Kessler, J., Van Der Ven, C., Weber-Luxenburger, G., Albers, M. & Heiss, W. D. (1998) Neuropsychologia 36, 77-82.
48. Deutsch, S. I., Rosse, R. B., Schwartz, B. L. & Mastropaolo, J. (2001) Clin. Neuropharmacol. 24, 43-49.